Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Immunization with Commercial Vaccines in HIV
NCT00329251Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2003
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Hepatitis A virus vaccine, Hepatitis B vaccine, influenza vaccine, diphtheria toxoid adsorbed + tetanus toxoid adsorbed, varicella virus vaccine live and 1 more in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Times viral load increases over 20,000 copies/mL. Started Apr 2003; status: completed.
02
Drugs
Hepatitis A virus vaccineHepatitis B vaccineinfluenza vaccinediphtheria toxoid adsorbed + tetanus toxoid adsorbedvaricella virus vaccine live
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00329251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329251.